Benign Gynecologic ConditionsNCT07496814
Comparison of the Outcomes of Total Laparoscopic Hysterectomy Versus Total Abdominal Hysterectomy for Benign Gynecologic Conditions in a Limited-resources Setting.
An observational study of Benign Gynecologic Conditions, run by Assiut University.
Trial summary
Minimally invasive hysterectomy (laparoscopic) is associated with shorter hospital stay, less blood loss, faster recovery, and improved early postoperative quality of life compared with open abdominal hysterectomy. Read more about this study
- Who is it for?
- Ages 35 to 65 years, women only
- Conditions the study is for
- Benign Gynecologic Conditions
- How many people
- 32 participants
- Where
- No sites listed yet
- Study dates
- Apr 2026to Dec 2027
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 35 to 65 years
- Women only
- No healthy volunteers
- Adult, Older adult
Study population: female patient who Indication for elective hysterectomy for benign disease.
Who may be able to join
- Women aged 35-65 years.
- Indication for elective hysterectomy for benign disease.
- Uterine size ≤ 16 weeks.
Who cannot join
- Malignancy or suspicion of malignancy.
- Prior extensive abdominal surgery with dense adhesions.
- Morbid obesity, BMI more than 40
- Severe cardiopulmonary disease.
- Pregnancy.
- Refusal participates in study
About this study
Minimally invasive hysterectomy (laparoscopic) is associated with shorter hospital stay, less blood loss, faster recovery, and improved early postoperative quality of life compared with open abdominal hysterectomy. However, in low-resource settings, barriers such as equipment availability, cost, and limited surgeon experience may influence outcomes.
- Conditions
- Benign Gynecologic Conditions
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Group A | patients who have total Laparoscopic Hysterectomyfor benign gynecologic conditions | |
| study group | patients have total Abdominal Hysterectomy for benign gynecologic conditions |
What is being measured
The primary outcome is the main question the study is designed to answer.
length of postoperative hospital stay
Measured: beseline
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted27 Mar 2026
- Study startApr 2026 (estimated)
- Primary completionApr 2027 (estimated)
- Study completionDec 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Benign Gynecologic ConditionsStudies of the same condition, open and under way.
- More trials run by Assiut UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 32 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Assiut University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Momahed Ahmed Fayek, Assiut University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07496814
- Sponsor's protocol ID
- Lap VS abd Hysterectom
- Status last verified
- Mar 2026
- First submitted
- 23 Mar 2026
- Last updated
- 27 Mar 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 27 Mar 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Comparison of the Outcomes of Total Laparoscopic Hysterectomy Versus Total Abdominal Hysterectomy for Benign Gynecologic Conditions in a Limited-resources Setting.
- ClinicalTrials.gov ID
- NCT07496814
- Acronym / sponsor ID
- Lap VS abd Hysterectom
- Conditions
- Benign Gynecologic Conditions
- Study type
- Observational
- Recruitment status
- Not yet recruiting
- Enrolment
- 32 participants (estimated)
- Lead sponsor
- Assiut UniversityUniversity, hospital or other
- Study start
- Apr 2026 (estimated)
- Primary completion
- Apr 2027 (estimated)
- Study completion
- Dec 2027 (estimated)
- First posted
- 27 Mar 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Minimally invasive hysterectomy (laparoscopic) is associated with shorter hospital stay, less blood loss, faster recovery, and improved early postoperative quality of life compared with open abdominal hysterectomy. However, in low-resource settings, barriers such as equipment availability, cost, and limited surgeon experience may influence outcomes.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Group A | – | –patients who have total Laparoscopic Hysterectomyfor benign gynecologic conditions |
| study group | – | –patients have total Abdominal Hysterectomy for benign gynecologic conditions |
Who may qualify
- Ages
- 35 to 65 years
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- female patient who Indication for elective hysterectomy for benign disease.
Key inclusion criteria (3 listed)
- Women aged 35-65 years.
- Indication for elective hysterectomy for benign disease.
- Uterine size ≤ 16 weeks.
Key exclusion criteria (6 listed)
- Malignancy or suspicion of malignancy.
- Prior extensive abdominal surgery with dense adhesions.
- Morbid obesity, BMI more than 40
- Severe cardiopulmonary disease.
- Pregnancy.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
length of postoperative hospital stay
Time frame: beseline
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 27 Mar 2026.
Related trials for Benign Gynecologic Conditions
RecruitingPhase 4
Bupivacaine With Epinephrine Over Diaphragm in Laparoscopy
Postoperative Pain, Shoulder Pain
Recruiting
Effect of Voiding Position (Standing in the Shower vs. Sitting) on Post-Void Residual Urine Volume (PVR) After Removal of Urinary Catheter in Women Following Benign Vaginal Gynecologic Surgery
Post-void Residual Volume, Recatheterization
Not yet recruiting
A Randomized Study Comparing Subtotal vs Total Hysterectomy Long Term Outcomes
Fibroid Uterus, Metrorrhagia
Recruiting
Low Versus Standard Pressure Pneumoperitoneum on Shoulder Tip Pain
Surgery, Laparoscopic
Recruiting
Assessment of Women's Sexual Quality of Life After Benign Adnexal Surgery Using vNOTES Approach
Gynecologic Disease, Adnexal Mass
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
An observational study of Benign Gynecologic Conditions, run by Assiut University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 27 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
length of postoperative hospital stay (time frame: beseline). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Mar 2026.